Cat. No. 0357
Biological ActivityA partial agonist for melatonin receptors in the retina. Also used for determination of serotonin N-acetyl transferase.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Dubocovich (1995) Melatonin receptors: are there multiple subtypes? TiPS 16 50. PMID: 7762083.
Thomas et al (1990) Arylalkylamine (serotonin) N-acetyl transferase assay using high-performance liquid-chromatography with fluorescence or electrochemical detection of N-acetyltryptamine. Anal.Biochem. 184 228. PMID: 2327568.
Dubocovich (1988) Luzindole (NO 774): a novel melatonin receptor antagonist. J.Pharmacol.Exp.Ther. 246 902. PMID: 2843633.
Dubocovich (1985) Characterization of a retinal melatonin receptor. J.Pharmacol.Exp.Ther. 234 395. PMID: 2991499.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses N-Acetyltryptamine from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: N-Acetyltryptamine, supplier, Melatonin, partial, agonists, MT1, MT2, MT3, antagonists, Serotonin, N-acetyltransferase, Substrate, serotonin, N-acetyl, transferase, MT, Receptors, 5-HT3, 5-Hydroxytryptamine, 5-HT, Transferases, activators, Tocris Bioscience, Other Transferase Substrate products
Find multiple products by catalog number
New Products in this Area
Carnitine palmitoyltransferase 1 and 2 (CPT1/2) inhibitorMS 023 dihydrochloride
Potent and selective type I PRMT inhibitorP-3FAX-Neu5Ac
Sialic acid analog; sialyltransferase inhibitorTolcapone
COMT inhibitor; also inhibits transthyretin aggregationJNJ DGAT2-A
DGAT2 inhibitorLLY 507
Potent SMYD2 inhibitor
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.